NCT03131531Recruiting
Bergamo Lymphoid Cancer Registry
Source: ClinicalTrials.gov · Last updated 6 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6000 (estimated)
- First submitted
- 20 Apr 2017
- Start date
- 23 Mar 2017
- Primary completion date
- 23 Mar 2027
- Lead sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Diseases
- Hodgkin lymphoma, Multiple myeloma
- NCT number
- NCT03131531
What you commit to
- Study type: Observational
- Planned participants: 6000
- From 23 Mar 2017 to the primary completion date, 23 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Who the study is looking for
- Male or female patients 18 years or older
- Written informed consent
- Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII Coordinator of this site? Confirm its status | Bergamo | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.